Women's lschemia Trial to Reduce Events in Non-Obstructive CAD (WARRIOR)
Abstract
The WARRIOR trial is a multicenter, prospective, randomized, blinded outcome evaluation (PROBE design) evaluating intensive medical therapy vs usual care in 4,422 symptomatic women with ischemia but no obstructive CAD. The study aims are to determine whether an intensive medication treatment strategy to modify risk factors in women with chest pain and abnormal stress tests but non obstructed coronary arteries will reduce their likelihood of dying, having a heart attack, stroke or being hospitalized. This project will activate 50-125 recruitment sites from across the US to enroll patients and follow these women for up to three years to assess adverse outcomes.
Document Details
- Document Type
- Technical Report
- Publication Date
- Oct 01, 2019
- Accession Number
- AD1086494
Entities
People
- Carl J Pepine
Organizations
- University of Florida